← Leaderboards
Didier Portilla
University Of Arkansas Med Scis Ltl Rock
$5,836,309
Attributed
$5,836,309
Total exposure
7
Grants
5
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $646.3K · FY2007–25$1M$750K$500K$250K$0
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$5,836,309 · 6
VA$0 · 1
By mechanism
R01$3,441,875 · 3
TL1$1,894,728 · 1
T32$499,706 · 1
I01$0 · 1
P01$0 · 1
Top collaborators
No co-investigators on record.
Most similar at University Of Arkansas Med Scis Ltl Rock
Same institution · by research overlap
- Hartmut W Jaeschke$17,580,334
- Sudhir V Shah$1,193,295
- Grant W Wangila$387,964
Others in their field
Top investigators on “Kidney”
- Jeffrey P Krischer · University Of South Florida$540,222,210
- John M Lachin · George Washington University$155,894,464
- David M Nathan · Massachusetts Institute Of Technology$127,229,266
- Kathryn Hirst · Caritas St. Elizabeth'S Medical Center$111,521,899
- David Heimbrook · Leidos Biomedical Research, Inc.$83,221,586
- Peter Scott Heeger · Case Western Reserve University$80,562,246
Research focus
KidneyCisplatinLigandsMediatingReperfusion InjuryAcute Renal Failure With Renal Papillary NecrosisPreventAffectInflammationIschemiaCell DeathPpar AlphaUniversitiesWild Type MouseRenal FunctionMetabolismLipidsIn VivoInflammatoryKidney DiseasesTransgenic MiceCellsMorbidity - Disease RatePathogenesis
Grant awards (29)
IGNITE KUH NRSA Training Core$364,016
TL1 · FY2025 · DK · contact PI
IGNITE KUH NRSA Training Core$354,046
TL1 · FY2024 · DK · contact PI
IGNITE KUH NRSA Training Core$385,163
TL1 · FY2023 · DK · contact PI
IGNITE KUH NRSA Training Core$404,003
TL1 · FY2022 · DK · contact PI
Role of intracellular complement activation in kidney fibrosis$242,250
R01 · FY2022 · DK · contact PI
IGNITE KUH NRSA Training Core$387,500
TL1 · FY2021 · DK · contact PI
Role of intracellular complement activation in kidney fibrosis$242,250
R01 · FY2021 · DK · contact PI
Role of intracellular complement activation in kidney fibrosis$242,250
R01 · FY2020 · DK · contact PI
Role of PPARalpha in Acute Kidney Injury$439,384
R01 · FY2016 · DK · contact PI
Role of PPARalpha in Acute Kidney Injury$439,384
R01 · FY2015 · DK · contact PI
Role of PPARalpha in Acute Kidney Injury$393,322
R01 · FY2014 · DK · contact PI
Role of PPARalpha in acute kidney injury$26,893
R01 · FY2014 · DK · contact PI
Role of PPARa on renal fibrosis$0
I01 · FY2014 · VA · contact PI
Role of PPARalpha in acute kidney injury$347,019
R01 · FY2013 · DK · contact PI
Training Program in the Pathophysiology of Renal Disease$121,684
T32 · FY2013 · DK · contact PI
Training Program in the Pathophysiology of Renal Disease$126,290
T32 · FY2012 · DK · contact PI
Role of apolipoprotein M in acute kidney injury$0
I01 · FY2012 · VA · contact PI
Role of apolipoprotein M in acute kidney injury$0
I01 · FY2011 · VA · contact PI
Role of apolipoprotein M in acute kidney injury$0
I01 · FY2011 · VA · contact PI
Role of PPARalpha and L-FABP in Acute Renal Failure$225,543
R01 · FY2010 · DK · contact PI
Training Program in the Pathophysiology of Renal Disease$131,065
T32 · FY2010 · DK · contact PI
Role of PPARalpha and L-FABP in Acute Renal Failure$227,821
R01 · FY2009 · DK · contact PI
Training Program in the Pathophysiology of Renal Disease$120,667
T32 · FY2009 · DK · contact PI
Role of apolipoprotein M in acute kidney injury$0
I01 · FY2009 · VA · contact PI
Role of PPARalpha and L-FABP in Acute Renal Failure$227,821
R01 · FY2008 · DK · contact PI
Role of PPARalpha and L-FABP in Acute Renal Failure$226,074
R01 · FY2007 · DK · contact PI
Gene Expression During Toxic Injury to proximal tubule$0
P01 · FY2002 · DK
Gene Expression During Toxic Injury to proximal tubule$0
P01 · FY2001 · DK
CALCIUM INDEPENDENT PLA2 AND ISCHEMIC CELL INJURY$161,864
R01 · FY2000 · DK